Q1 2018 13F Holders as of 3/31/2018
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
119M
-
Number of holders
-
118
-
Total 13F shares, excl. options
-
36.8M
-
Shares change
-
-1.57M
-
Total reported value, excl. options
-
$265M
-
Value change
-
-$12.3M
-
Put/Call ratio
-
0.64
-
Number of buys
-
48
-
Number of sells
-
-58
-
Price
-
$7.20
Significant Holders of CYTOKINETICS INC - COMMON STOCK (CYTK) as of Q1 2018
142 filings reported holding CYTK - CYTOKINETICS INC - COMMON STOCK as of Q1 2018.
CYTOKINETICS INC - COMMON STOCK (CYTK) has 118 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 36.8M shares
of 119M outstanding shares and own 30.87% of the company stock.
Largest 10 shareholders include BlackRock Inc. (7.26M shares), BVF INC/IL (5.72M shares), VANGUARD GROUP INC (3.39M shares), LANSDOWNE PARTNERS (UK) LLP (2.65M shares), STATE STREET CORP (2.36M shares), FMR LLC (2.29M shares), WELLINGTON MANAGEMENT GROUP LLP (2.02M shares), WASATCH ADVISORS INC (1.76M shares), PINNACLE ASSOCIATES LTD (888K shares), and CITIGROUP INC (772K shares).
This table shows the top 118 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.